Side effects of Atorvastatin 

  1. Myalgia
  2. Myopathy
  3. Muscle Weakness 
  4. Muscle Spasm 
  5. Headache

Proprotein Convertase Subtilisin/Kexin Type – 9 (PCSK9) Inhibitors

ð PCSK9 is synthesised in inactive form by many tissues, including brain and liver. It is activated autocatalytically by proteolytic cleavage, which removes a section of its peptide chain that blocks its activity.

ð When activated, it binds to LDL receptors and promotes their lysosomal degradation (following LDL uptake into hepatocyte cytoplasm), thereby preventing recycling of LDL receptors to the surface membrane, and diminishing their ability to sequester LDL.

*    The PCSK9 inhibitors binds with PCSK9 enzyme thereby inhibiting it to bind with the LDL receptor, so that the lysosomal degradation of LDL receptors not happens and the recycling of LDL receptors to the hepatocyte membrane occurs.

 ð Drugs – Evolocumab, Alirocumab





Comments

Popular posts from this blog